Department Blog

  • Truvada for PrEP, an HIV antiretroviral drug
    Permalink Gallery

    Social norms, contractualism and public policy: How gender affects epidemiology

Social norms, contractualism and public policy: How gender affects epidemiology

29 March 2022|

How do social norms influence the effectiveness of public policy, and what are the moral, political and philosophical implications of taking social norms seriously? Elsa Kugelberg looks at the effect of gender norms on health policy.

What else is ending and what is beginning?

16 March 2022|

What does the future hold for analytic and experimental philosophy? Petr Jedlička looks at current research methods and asks where the next generation of philosophers might lead us.

Philosophy and Neurodiversity

2 March 2022|

What is neurodiversity, and what does it mean for philosophy? Sam Crutcher explores how “divergent worldviews” shape philosophical insight and discussion.

The devil’s in the framing: language and bias

8 February 2022|

How we say things can be as important as what we say. In this post, Ella Whiteley explores the “framing effect” and its implications for discussions of sex and gender.

The dangers of single metric accounting in public policy

26 January 2022|

How should policy-makers measure the impact of far-reaching policies? Johanna Thoma looks at some of the issues involved in relying on a single metric.

How to respond to Omicron: lessons from Alpha

7 December 2021|

When advisors warned of “significant concerns” about the Alpha variant, the UK government acted quickly. But suspicions about Alpha’s greater transmissibility were first noted a week earlier. Jonathan Birch suggests that when the stakes are so high, even low confidence in a particular outcome can be enough to justify policy interventions.

In the Name of Europe

24 August 2021|

How should philosophical writing employ the first-person plural, “we”? Simon Glendinning reflects on his recent work on the philosophy of Europe.

  • Permalink Gallery

    Statins and CVD (Cardio-Vascular Disease): Now It’s Personal!

Statins and CVD (Cardio-Vascular Disease): Now It’s Personal!

29 June 2021|

What does the evidence say about the effectiveness of statins and about the balance between effectiveness and possible adverse side-effects? John Worrall – a long-time analyst of evidence in medicine – has recently had personal reason to reconsider these questions.

  • Permalink Gallery

    How should artificial agents make risky choices on our behalf?

How should artificial agents make risky choices on our behalf?

8 June 2021|

Should artificial agents’ responses to difficult choices align with our own moral intuitions? Johanna Thoma considers the difficulties involved in programming machines to deal with risk, and how things look different from an aggregate point of view.

  • Permalink Gallery

    How studying the history and philosophy of RNA can help us understand COVID-19

How studying the history and philosophy of RNA can help us understand COVID-19

25 May 2021|

How can the philosophy of science help inform our response to COVID-19? Stephan Guttinger looks at the history and philosophy of ribonucleic acid (RNA), a central but often overlooked molecule in the story of the pandemic.